Giant DNA Origami

Researchers create the largest 3-D DNA structures to date, many times bigger than previously constructed origami shapes.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, MEHMET PINARCIDNA origami, a strategy devised eight years ago by Paul Rothemund’s group at Caltech, allows researchers to link DNA scaffolds with smaller bits of the nucleic acid called staples to create desired shapes. The technique is now being used to develop drug-delivery systems and other molecular machines. But the most common technique—using an M13 bacteriophage to generate single-stranded DNA scaffolds of up to 7 kilobases—has restricted the size of the products to tens of square nanometers. Double-stranded DNA could be produced at longer lengths, but was limited in its ability to fold at a researchers’ will. Now, Thomas LaBean of North Carolina State University and colleagues have devised a solution: using a hybrid virus for DNA production, the researchers can generate scaffolds of up to 51 kilobases—and they’ve used these to create DNA structures that are hundreds of square nanometers in size, Chemical & Engineering News (C&EN) reported.

“They’ve achieved something people have been trying to do for a while,” Rothemund told C&EN.

To fold giant pieces of DNA, LaBean’s team used more than 1,600 staples. According to C&EN, such a task would have cost $7,000 using conventional DNA synthesis. So to reduce the cost, the team repurposed an ink-jet printer to synthesize the DNA, using reusable templates and chips with polymer micropillars, then amplified the produces using PCR.

“We had to do two things to make this viable,” lead author Alexandria Marchi of Duke University said in a press release. “First we had to develop a custom scaffold strand that contained 51 kilobases. . . . Second, in order to make this economically feasible, we had to find a cost-effective way of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies